•
Mar 31, 2022

ImmunityBio Q1 2022 Earnings Report

Total Revenue
$14K
Previous year: $139K
-89.9%
EPS
-$0.26
Previous year: -$0.21
+23.8%
Gross Profit
-$5.39M
Previous year: $139K
-3980.6%
Cash and Equivalents
$36.4M
Previous year: $44.7M
-18.6%
Free Cash Flow
-$102M
Previous year: -$67.6M
+51.4%
Total Assets
$390M
Previous year: $209M
+86.0%

ImmunityBio

ImmunityBio

ImmunityBio Revenue by Segment